Prescription Drug Affordability Board

  1. Law
  2. Maryland Code
  3. General
  4. Food, Drugs, and Cosmetics
  5. Prescription Drug Affordability Board

Checkout our iOS App for a better way to browser and research.

Section
21-2C-01

Definitions.

Section
21-2C-02

Prescription Drug Affordability Board.

Section
21-2C-03

Membership.

Section
21-2C-04

Prescription Drug Affordability Stakeholder Council.

Section
21-2C-05

Disclosure of conflicts of interest.

Section
21-2C-06

Acceptance of gratuities prohibited.

Section
21-2C-07

Study and report -- Pharmaceutical distribution and payment system in State; policy options used in other states and countries.

Section
21-2C-08

Collection, review, and use of transparency data for prescription drug products.

Section
21-2C-09

Cost review of prescription drug products with affordability challenges.

Section
21-2C-10

Confidentiality.

Section
21-2C-11

Funding source.

Section
21-2C-12

Enforcement.

Section
21-2C-13

Drafting action plan for implementing process to set upper payment limits for prescription drug products

Section
21-2C-13

Drafting action plan for implementing process to set upper payment limits for prescription drug products. (Abrogation of section effective January 1, 2023.)

Section
21-2C-14

Appeals of Board decisions

Section
21-2C-15

Board and Stakeholder Council report and recommendation concerning upper payment limits